共查询到20条相似文献，搜索用时 234 毫秒
1.
为掌握H5N1高致病性禽流感疫苗免疫效价,了解乌鲁木齐市米东区鸡群禽流感免疫抗体水平,对该地区不同鸡场进行了禽流感抗体检测。结果表明,40只免疫鸡,免疫抗体效价合格数33只,总合格率为82.5%。说明近几年对高致病性禽流感采取的强制免疫措施达到了比较显著的效果。 相似文献
2.
为分析蛋鸡免疫后卵黄抗体与血清抗体的相关性,试验采集经H5、H9亚型禽流感和新城疫疫苗免疫的黔东南小香鸡、乌蒙乌骨鸡、威宁鸡血清样本和卵黄样本,采用血凝抑制试验进行相关免疫抗体检测。结果:3个地方品种鸡的血清样本和卵黄样本中均可检测出H5、H9亚型禽流感和新城疫免疫抗体,且几何平均效价均大于24以上,达到免疫合格标准,不同地方品种鸡群间差异不显著(P>0.05);免疫后30d,卵黄样本免疫抗体几何平均效价低于血清样本,但差异不显著(P>0.05);免疫后60d,卵黄样本免疫抗体几何平均效价低于血清样本,差异显著(P<0.05)。结果表明:卵黄抗体与血清抗体呈正相关性,卵黄抗体几何平均效价均低于血清抗体。在临床上可用卵黄抗体替代血清抗体进行H5、H9亚型禽流感和新城疫疫苗免疫效果的评价,但应选择在免疫后30d以内。 相似文献
3.
4.
《动物医学进展》2021,42(4)
为评价H9N2亚型禽流感病毒HF株灭活疫苗对流行毒株的免疫保护效果,将禽流感病毒HF株灭活疫苗和商品化鸡新城疫、禽流感(H9亚型)二联灭活疫苗分别以0.3 mL/只接种21日龄SPF鸡,3周后采血测定HI抗体效价,并用2018年-2019年分离的4株H9亚型禽流感病毒分别进行攻毒。结果显示,免疫后21 d, HF株灭活疫苗免疫组HI抗体效价达到9.1 log2以上,商品化疫苗HI抗体效价几何平均值则为6.3 log2以内。4株H9亚型禽流感病毒流行毒株以10~(7.0)EID_(50)的剂量静脉攻毒后,HF株灭活疫苗免疫组可抵抗流行毒株的攻击,保护率为100%;而商品化疫苗对流行毒株的攻毒保护率仅为40%～60%。说明H9N2亚型禽流感病毒HF株灭活疫苗具有较强的免疫原性,能使免疫鸡抵抗流行毒株的攻击。 相似文献
5.
6.
目的 分析与评估禽流感疫苗对禽类的免疫效果.方法 采用疫苗接种、抗体试验和分组试验法,在非疫区对禽类用H5亚型和H5、H9二价禽流感油乳苗进行免疫接种试验,并对结果分析比较.结果 不同日龄蛋鸡免疫接种20天后HI抗体效价不同、饲养方式不同、家禽种类不同疫苗效果不同.85日龄蛋鸡产生的HI抗体效价达到7log2,鸡、鸭、鹅混养HI抗体效价低于平养和笼养,H5亚型禽流感疫苗免疫鸡和鸽其HI抗体效价达到了5log2以上,而对鹌鹑和鸭为1log2和3.2log2.结论 单价禽流感疫苗和二价疫苗对鸡群免疫的效果不同,2价疫苗的免疫效果较单价疫苗差. 相似文献
7.
我局对124户养禽户采集了2218份不同禽群血样进行了禽流感H5抗体水平监测,免疫合格血清样本为1752份,总体免疫合格率为78.99%,平均HI效价为26.45,标准差为22.03。其中鸡群免疫合格率为76.58%,平均HI效价为26.18,标准差为22.16;鸭群免疫合格率为80.96%,平均HI效价为26.71,标准差为22.00;鹅群免疫合格率为83.33%,平均HI效价为26.82,标准差为21.12。 相似文献
8.
通过使用新城疫和禽流感的二联浓缩疫苗免疫生产鸡群，分别在免疫后的不同时间进行翅静脉采血，检测鸡群中ND、AI（H9）HI的血清抗体水平。结果显示，免疫组鸡的抗体效价3周达到高峰，ND达到8log2以上，AIH9达到9log2以上，维持在较高水平达20周以上。结果表明浓缩疫苗在肉种鸡上的应用效果较好。 相似文献
9.
为了研究成都天邦生物制品有限公司生产的鸡新城疫(基因Ⅶ型)、禽流感(H9亚型)二联灭活疫苗(aSG10株+G株)对蛋鸡的安全性和免疫效果,在北京市华都峪口禽业有限责任公司京红1号蛋鸡养殖场进行相关试验。结果显示:疫苗经不同免疫途径(皮下注射和肌肉注射)、不同免疫剂量(单剂量和超剂量)接种115日龄蛋鸡后,未见任何不良反应,注射部位疫苗吸收良好,产蛋率与空白对照组无明显差异。试验鸡免疫后14d,新城疫HI抗体平均滴度为10.9log2,H9亚型禽流感HI抗体平均滴度为9.1log2,免疫后6个月新城疫HI抗体水平不低于6.9log2,H9亚型禽流感HI抗体水平不低于7.4log2。分别于免疫后21d和6个月对免疫鸡进行攻毒,新城疫攻毒保护率为100%,禽流感攻毒保护率为95%。表明该二联苗对蛋鸡安全、有效,且免疫持续期长,可用于蛋鸡的免疫。 相似文献
10.
禽流感疫苗对禽类免疫效果的检测与分析 总被引：4，自引：2，他引：4
禽流感大流行时，在非疫区对禽类用H5亚型和H5、H9二价禽流感油乳苗进行免疫接种试验，并对其结果进行比较和分析。得出不同日龄的蛋鸡免疫接种20d后其HI抗体效价不同，不同的饲养方式、不同种类的家禽及不同种类疫苗的免疫效果均不同。85日龄蛋鸡产生的HI抗体效价达到7log2，鸡、鸭、鹅混养HI抗体效价低于平养和笼养，H5亚型禽流感疫苗免疫鸡和鸽其HI抗体效价达到了5log2以上，而对鹌鹑和鸭为1log2和3．2log2；单价禽流感疫苗和二价苗对鸡群免疫的效果不同，二价苗的免疫效果不如单价苗。 相似文献
11.
12.
猪胸膜肺炎调查及地方适用型灭活疫苗的研制 总被引：1，自引：0，他引：1
对广东珠江三角洲地区31个猪场450份血清用IHA方法进行猪胸膜肺炎放线杆菌(APP)抗体检查,阳性猪场和阳性血清分别为96.8%和58.4%;分离鉴定了7株APP,血清分型为1、7、3和4型,且以1、7型毒力较强;用平板凝集法对263份APP抗体阳性血清进行抗体反向分型试验,结果1型、7型共占76.4%。确定了APP最佳液体培养条件,培养菌液CFU为2.4×109/mL;研制的APP 1型、7型二价灭活疫苗安全、稳定。兔和仔猪免疫抗体曲线显示,油乳剂疫苗明显优于铝胶疫苗,二次免疫优于一次免疫;APP双价油乳剂灭活疫苗一次免疫仔猪,能100%抵抗APP同源1、7型强毒菌株的攻击,保护期达110 d;田间试验明显提高猪群的生产成绩。 相似文献
13.
随机抽取安徽省3个肉种鸡场种鸡及3个地市农贸市场商品鸡的血清样本和泄殖腔拭子,采用ELISA进行鸡白血病检测,并对J亚群鸡白血病病毒抗体阳性鸡群中病鸡的肝组织、全血及上毒细胞提取DNA进行PCR扩增和基因测序。检测结果表明,3个肉种鸡场中J亚群鸡白血病抗体阳性检出率分别为：0、73.50%和15.22%;3个农贸市场商品鸡抗体阳性检出率分别为：12.00%、2.22%和9.10%。3个肉种鸡场A、B亚群鸡白血病的抗体阳性率分别为0、17.93%和1.08%,ALV抗原阳性率分别为2.17%、17.93%和15.22%。PCR检测结果表明,从可疑发病鸡的肝组织和全血中均能扩增出ALV-J gp85特异性片段。结果证实安徽省鸡群中有ALV-J感染,并呈不同程度的流行,应引起高度重视。 相似文献
14.
Protective efficacy of commercial Newcastle disease vaccines against challenge of goose origin virulent Newcastle disease virus in geese 总被引：1，自引：0，他引：1
Since 1997, severe outbreaks of Newcastle disease (ND) in geese in many regions throughout China have resulted in high morbidity and mortality, and great economic loss to farmers; however, no licensed, specific vaccine is yet available for this disease in China. In this study, goslings were immunized with different combinations and dosages of several commercial ND vaccines including La Sota vaccine, Mukteswar vaccine, recombinant live vaccine against avian influenza (AI) and ND (rL-H5 strain), and inactivated ND oil-emulsion vaccine (La Sota strain). The protective effects were evaluated based upon the level of antibody response and the degree of protection against the goose-origin virulent NDV strain. The result showed that two doses (i.e., one more than that for chicken) of La Sota vaccine priming, followed by 2-5 doses of Mukteswar vaccine boosting 2-3 weeks later, not only induced higher HI antibody levels, but also conferred longer-lasting protection. This immunization procedure can be recommended for prevention of ND in geese. 相似文献
15.
禽霍乱蜂胶灭活疫苗对鸡鸭鹅的现场免疫应用效果 总被引：1，自引：1，他引：0
对鸡、鸭、鹅健康群和禽霍乱发病群现场应用禽霍乱蜂胶灭活疫苗，结果表明，该疫苗安全可靠，不影响开产日龄和产蛋；保护率高，４个月内保护率为９８．７％～１００％，６个月内保护率为８５％～９５％，６个月以上保护率为６０％～８０％；对禽霍乱暴发群配合内服药物，可于５～７ｄ内迅速控制和扑灭疫情，且不复发 相似文献
16.
抗鸡新城疫和传染性法氏囊病二联卵黄抗体的研制及应用 总被引：2，自引：1，他引：1
用新城疫疫苗和传染性法氏囊病疫苗免疫健康高产蛋鸡制备抗鸡新城疫和传染性法氏囊病二联卵黄抗体,并在40个规模化肉鸡场做推广应用,结果表明,预防保护率达100%,治愈率为63%~85%。 相似文献
17.
将鸡新城疫、禽流感（H9亚型,SY株）二联灭活疫苗与市售同类对照苗分不同剂量皮下注射接种30日龄SPF鸡,免疫后定期采血,分离血清,通过检测血清中ND和AI的HI抗体水平比较各组鸡抗体产生期、抗体高峰及免疫持续期,并进行不同血凝抗原检测HI抗体结果的对比。试验鸡血清样品检测结果显示,免疫鸡抗体产生期为免后2周内,免后8周和5周ND和AI的HI抗体滴度分别达到峰值,抗体至少可持续28周以上,两种灭活苗之间免疫效果基本相当。 相似文献
18.
Jeong-Hwa Shin Jong Seo Mo Jong-Nyeo Kim In-pil Mo Bong-Do Ha 《Journal of veterinary science (Suw?n-si, Korea)》2016,17(1):27-34
In Korea, several outbreaks of low pathogenic AI (H9N2) viral infections leading to decreased egg production and increased mortality have been reported on commercial farms since 1996, resulting in severe economic losses. To control the H9N2 LPAI endemic, the Korea Veterinary Authority has permitted the use of the inactivated H9N2 LPAI vaccine since 2007. In this study, we developed a killed vaccine using a low pathogenic H9N2 AI virus (A/chicken/Korea/ADL0401) and conducted safety and efficacy tests in commercial layer farms while focusing on analysis of factors that cause losses to farms, including egg production rate, egg abnormality, and feed efficiency. The egg production rate of the control group declined dramatically 5 days after the challenge. There were no changes in feed consumption of all three groups before the challenge, but rates of the control declined afterward. Clinical signs in the vaccinated groups were similar, and a slight decline in feed consumption was observed after challenge; however, this returned to normal more rapidly than the control group and commercial layers. Overall, the results of this study indicate that the safety and efficacy of the vaccine are adequate to provide protection against the AI field infection (H9N2) epidemic in Korea. 相似文献
19.
Alexandra Richard-Mazet Sylvain Goutebroze Fran?ois-Xavier Le Gros David E Swayne Michel Bublot 《Veterinary research》2014,45(1)
Inactivated and fowlpox virus (FP)-vectored vaccines have been used to control H5 avian influenza (AI) in poultry. In H5 AI endemic countries, breeder flocks are vaccinated and therefore, maternally-derived antibodies (MDA) are transferred to their progeny. Results of three immunogenicity and one efficacy studies performed in birds with or without MDA indicated that the immunogenicity of an inactivated vaccine based on a H5N9 AI isolate (inH5N9) was severely impaired in chicks hatched from inH5N9-vaccinated breeders. This MDA interference was lower when breeders received only one administration of the same vaccine and could be overcome by priming the chicks at day-of-age with a live recombinant FP-vectored vaccine with H5 avian influenza gene insert (FP-AI). The interference of anti-FP MDA was of lower intensity than the interference of anti-AI MDA. The highest interference observed on the prime-boost immunogenicity was in chicks hatched from breeders vaccinated with the same prime-boost scheme. The level of protection against an antigenic variant H5N1 highly pathogenic AI isolate from Indonesia against which the FP-AI or inH5N9 alone was poorly protective could be circumvented by the prime-boost regimen in birds with either FP or AI MDA. Thus, the immunogenicity of vaccines in young chicks with MDA depends on the vaccination scheme and the type of vaccine used in their parent flocks. The heterologous prime-boost in birds with MDA may at least partially overcome MDA interference on inactivated vaccine. 相似文献
20.
During the spring of 2002, a low pathogenic avian influenza (LPAI) A (H7N2) virus caused a major outbreak among commercial poultry in Virginia and adjacent states. The virus primarily affected turkey flocks, causing respiratory distress and decreased egg production. Experimentally, turkeys were more susceptible than chickens to H7N2 virus infection, with 50% bird infectious dose titers equal to 10(0.8) and 10(2.8-3.2), respectively. Comparison of virus shedding from the cloaca and oropharynx demonstrated that recent H7N2 virus isolates were readily isolated from the upper respiratory tract but rarely from the gastrointestinal tract. The outbreak of H7N2 virus raised concerns regarding the availability of vaccines that could be used for the prevention and control of this virus in poultry. We sought to determine if an existing commercial avian influenza (AI) vaccine prepared from a 1997 seed stock virus could provide protection against a 2002 LPAI H7N2 virus isolated from a turkey (A/turkey/Virginia/158512/02 [TV/02]) in Virginia that was from the same lineage as the vaccine virus. The inactivated AI vaccine, prepared from A/chicken/ Pennsylvania/21342/97 (CP/97) virus, significantly reduced viral shedding from vaccinated turkeys in comparison with sham controls but did not prevent infection. The protective effect of vaccination correlated with the level of virus-specific antibody because a second dose of vaccine increased antiviral serum immunoglobulin G and hemagglutination inhibition (HI) reactivity titers in two different turkey age groups. Serum from CP/97-vaccinated turkeys reacted equally well to CP/97 and TV/02 antigens by HI and enzyme-linked immunosorbent assay. These results demonstrate the potential benefit of using an antigenically related 1997 H7N2 virus as a vaccine candidate for protection in poultry against a H7N2 virus isolate from 2002. 相似文献